BICLUSTER_ID : UPREG-52
PATHOGENS /2/ : pseudomonas aeruginosa,escherichia coli
TARGETS /44/ : PLAT, HCK, GPR109B, CYP1B1, GFPT2, GCH1, UGCG, EGFR, CFB, NFKB1, PLG, MMP3, IL1B, HPN, F3, SELE, ICAM1, CKB, SMOX, CCL20, PDE4B, CCL2, CD40, CASP3, CASP7, CCND1, VCAM1, PLAU, IL3RA, AMPD3, CD40LG, CCL5, GP1BA, PIM1, GZMB, S100A11, TAP1, IFNGR2, IL6, PTGS2, IL8, TNF, PLAUR, HSPA1A
Gene SetLeading Edge Genes
NETPATH TNF ALPHA PATHWAY UPFOXF1, CSF3, RND1, OPTN, PMAIP1, NFKBIA, GCH1, UGCG, GDF10, CXCL1, CSF1, TNFAIP3, IL15RA, BID, IER2, NFKB2, CCL2, CLIC4, CASP7, TRAF1, VCAM1, PLAU, CXCL3, CCL5, PTX3, IER3, S100A11, TNFSF7, PPP1R15A, KLF10, IFNGR2, IL6, PTGS2, DUSP1, PSMB8, G0S2, SEC61B, INADL, STAT5A, BTG3, TNFSF8, GFPT2, CXCL2, RELB, CX3CL1, SOD2, EMP3, NFKB1, TNIP1, CPA3, TRAF3, BCL3, BCL2A1, FGF3, TNFAIP8, TNFAIP2, MMP3, IL1B, ALOX12P2, CHST2, SELE, ICAM1, IRF1, NFKBIB, SMOX, NFKBIE, BIRC2, CREB5, IL3RA, SDC4, CSF2, BIRC3, ADAM17, ETS2, IL8, PLAUR
NETPATH IL 2 PATHWAY UPDDX21, PFKFB3, BTG3, STAT5A, LYN, OLIG2, IRF4, NMI, PRKCE, PMAIP1, NFKB1, B4GALT5, CPA3, LIMK2, GADD45G, DENND3, SRC, BAG1, LCP2, IL1B, HPN, ICAM1, IRF1, UPP1, ZNF267, PDE4B, GBP1, CASP3, CCND1, RELA, SOCS3, PLAU, SOCS1, CD40LG, CASP10, FOSL2, CSF2, CYP7B1, GZMB, CCL4, IER3, TAF4B, KLF6, DUSP5, PRKY, ETS2, USP15, IL6, IL8, PLAUR, TNF, MX1
NETPATH IL 1 PATHWAY UPCCL20, NFKBIE, CCL2, RELA, CXCL3, NFKBIA, AMPD3, CXCL2, CSF2, SOD2, PTX3, CCL4, CFB, NFKB1, BIRC3, BMP1, CXCL1, JMJD3, TNFAIP6, CXCL5, MMP3, IL6, PTGS2, IL1B, ICAM1, IL8
NCI AMB2 NEUTROPHILS PATHWAYNFKB1, PLG, PLAT, LYN, HCK, MST1R, PLAU, IL6, ICAM1, LAMA2, GP1BA, PLAUR, TNF
NETPATH IL 5 PATHWAY UPNFKBIB, NFKB2, PDE4B, NFKBIE, CCL2, RELA, IL3RA, GPR109B, FOSL2, RELB, IER3, NFKB1, BIRC3, DUSP5, REL, TRAF3, LIMK2, RAB21, LCP2, IL1B, SELE, ICAM1, IL8, IER2
NETPATH IL 4 PATHWAY DOWNCCL20, CCL2, NFKBIA, MMP3, IL6, PTGS2, ICAM1, NINJ1, IRF1, IL8, CXCL2, EGFR
NETPATH B CELL RECEPTOR PATHWAY UPCCL22, EREG, TP53BP2, CCL2, HCK, IRF4, CYP1B1, TRAF1, GPR109B, ITGA8, DDR2, CCL5, DUSP8, AIM2, BIRC3, IFNGR2, BCL2A1, LCP2, TNFAIP3, ICAM1, IER2, TNF
NETPATH IL 4 PATHWAY UPCCL22, CCL2, TP53BP2, IL13RA2, CH25H, CASP3, RELA, SOCS3, VCAM1, CYP1B1, IL1RN, SULF1, SOCS1, INHBA, RIPK2, POSTN, PTX3, NFKB1, REL, IBRDC3, PSCD1, CEBPB, BCL3, RASGRP1, IL6, F3, SELE
NETPATH TNF ALPHA PATHWAY DOWNCKB, CCL20, CCND1, CXCL3, NFKBIA, SDC4, CXCL2, IER3, NFKB1, KLF6, CXCL1, PLK2, PPP1R15A, KLF10, MAFF, TNFAIP2, IL6, PTGS2, TNFAIP3, IRF1
NETPATH EGFR1 PATHWAY UPCDKN1A, EREG, PHLDA2, CCND1, LAD1, PLAU, DKK3, SDC4, MMP1, IER3, NAV3, PLK2, CXCL6, MMP7, EHD1, CXCL5, MMP3, PTGS2, TNFAIP3, PLAUR, DUSP1
NETPATH KIT RECEPTOR PATHWAY UPCCL22, CCL2, TAP1, CCND1, RELA, IL6, SOCS1, CCL5, CSF2, KITLG, IER3
NCI IL23PATHWAYNFKB1, CXCL1, CCL2, STAT5A, RELA, SOCS3, NFKBIA, IL6, IL1B
NETPATH IL 9 PATHWAY UPCCL2, JUNB, SELL, BCL3, IL5RA, SOCS3, CCL11, CCL7, PIM1, GZMB
NCI REG GR PATHWAYIL6, ICAM1, IRF1, IL8, STAT5A, CSF2, RELA
NCI P53DOWNSTREAMPATHWAYDUSP5, CDKN1A, TAP1, BCL2A1, PMAIP1, ATF3, PRMT1, CASP10, CX3CL1, HSPA1A, DUSP1, EGFR
GERY CEBP TARGETSCXCL1, EREG, PLAT, GADD45G, RRAD, TNFAIP6, ATF3, S100A3, GCH1, IER2, DUSP1, PLAUR, PTX3, POSTN
NCI ATF2 PATHWAYPLAU, SOCS3, IL6, ATF3, DUSP5, SELE, DUSP8, DUSP1
NETPATH IL 3 PATHWAY UPSOCS3, IL1B, SOCS1, CCL2, IL8, CCL4
NCI TNFPATHWAYNFKB1, BIRC3, BIRC2, ADAM17, RELA, TRAF1, TNFAIP3, TNF
NETPATH IL 7 PATHWAY UPCCL22, CXCL1, TRAF3, STAT5A, TNFSF8, CXCL3, CXCL5, CCL5, IL8, CXCL2, CASP10, CCL4
ST TUMOR NECROSIS FACTOR PATHWAYNFKB1, BIRC3, NFKB2, NFKBIE, BIRC2, CASP3, NFKBIA, TNFAIP3
SA MMP CYTOKINE CONNECTIONTNFSF8, IL1B, CSF1, SELL, TNF
NETPATH IL 1 PATHWAYNFKB1, NFKBIA, IL1B, RELA
NCI IL6 7PATHWAYSOCS3, IL6, TIMP1, CEBPD, CEBPB, IRF1, HCK
NCI IL1PATHWAYNFKB1, IL1B, RELA
NETPATH IL 6 PATHWAY UPCXCL1, CEBPB, BCL3, MAP3K8, SOCS3, MAFF, MMP3, SOCS1, IRF1, TNF
NCI CERAMIDE PATHWAYNFKB1, NFKBIA, BIRC3, BID, TNF, RELA
NCI CD40 PATHWAYNFKB1, BIRC3, TRAF3, CD40, STAT5A, BIRC2, RELA, TRAF1, NFKBIA, TNFAIP3
NCI NFKAPPABCANONICALPATHWAYNFKB1, NFKBIA, TNFAIP3, RIPK2, BIRC2, TNF, RELA
CORUM NFKB1-NFKB2-REL-RELA-RELB COMPLEXNFKB1, NFKB2, RELB, RELA
NCI REGULATED PROTEOLYSIS OF P75NTRNFKB1, ADAM17, RELA
NCI NF KB IS ACTIVATED AND SIGNALS SURVIVALNFKB1, NFKBIA, RELA
CORUM NFKB1-NFKB2-RELA-RELB COMPLEXNFKB1, NFKB2, RELB, RELA
NCI NFKAPPABATYPICALPATHWAYNFKB1, NFKBIA, BCL3, RELA
CORUM CHUK-NFKB2-REL-IKBKG-SPAG9-NFKB1-NFKBIE-COPB2-TNIP1-NFKBIA-RELA-TNIP2 COMPLEXNFKB1, NFKBIA, TNIP1, NFKB2, NFKBIE, RELA
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
BIOCARTA STEM PATHWAY
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
BIOCARTA IL6 PATHWAY
PIEPOLI LGI1 TARGETS DN
LINDGREN BLADDER CANCER CLUSTER 2B
NCI ERBB NETWORK PATHWAY
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
BIOCARTA RELA PATHWAY
RASHI RESPONSE TO IONIZING RADIATION 2
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
ODONNELL TFRC TARGETS UP
KEGG HYPERTROPHIC CARDIOMYOPATHY HCM
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
AMIT EGF RESPONSE 40 HELA
TOMIDA METASTASIS UP
AMIT EGF RESPONSE 480 HELA
JEON SMAD6 TARGETS UP
MITSIADES RESPONSE TO APLIDIN UP
KEGG COMPLEMENT AND COAGULATION CASCADES
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
HASINA NOL7 TARGETS UP
NCI DISSOLUTION OF FIBRIN CLOT
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
LENAOUR DENDRITIC CELL MATURATION DN
SABATES COLORECTAL ADENOMA DN
HINATA NFKB TARGETS KERATINOCYTE UP
GENTILE UV HIGH DOSE UP
DORN ADENOVIRUS INFECTION 48HR DN
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
MARKEY RB1 ACUTE LOF UP
SCHEIDEREIT IKK INTERACTING PROTEINS
REACTOME INTRINSIC PATHWAY FOR APOPTOSIS
AMIT SERUM RESPONSE 60 MCF10A
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
SABATES COLORECTAL ADENOMA UP
WOTTON RUNX TARGETS UP
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
BIOCARTA CD40 PATHWAY
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
AMIT EGF RESPONSE 120 HELA
BIOCARTA RANKL PATHWAY
VART KSHV INFECTION ANGIOGENIC MARKERS DN
MCLACHLAN DENTAL CARIES UP
BIOCARTA AKT PATHWAY
GAJATE RESPONSE TO TRABECTEDIN UP
PODAR RESPONSE TO ADAPHOSTIN UP
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
HOSHIDA LIVER CANCER SUBCLASS S1
REACTOME HUMAN TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX
HELLER SILENCED BY METHYLATION UP
KERLEY RESPONSE TO CISPLATIN UP
BIOCARTA CARDIACEGF PATHWAY
LAU APOPTOSIS CDKN2A UP
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
DORN ADENOVIRUS INFECTION 24HR DN
BIOCARTA IL17 PATHWAY
FALVELLA SMOKERS WITH LUNG CANCER
VERHAAK AML WITH NPM1 MUTATED UP
REACTOME G ALPHA I SIGNALLING EVENTS
RUGO STRESS RESPONSE SUBSET F
REACTOME HDL MEDIATED LIPID TRANSPORT
SA CASPASE CASCADE
SENGUPTA NASOPHARYNGEAL CARCINOMA WITH LMP1 DN
CHASSOT SKIN WOUND
TIAN TNF SIGNALING VIA NFKB
CHARAFE BREAST CANCER BASAL VS MESENCHYMAL DN
HUMMEL BURKITTS LYMPHOMA DN
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
MURAKAMI UV RESPONSE 1HR DN
BIOCARTA IL3 PATHWAY
GENTILE UV LOW DOSE UP
GOLUB ALL VS AML DN
KEGG APOPTOSIS
SHEN SMARCA2 TARGETS DN
HOFMANN MYELODYSPLASTIC SYNDROM LOW RISK DN
PEREZ TP63 TARGETS
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
HINATA NFKB TARGETS FIBROBLAST UP
MISSIAGLIA REGULATED BY METHYLATION UP
CORUM MURR1-NFKAPPABP65-IKBA COMPLEX
CROONQUIST STROMAL STIMULATION UP
BIOCARTA TALL1 PATHWAY
BLUM RESPONSE TO SALIRASIB UP
NCI NFKAPPABALTERNATIVEPATHWAY
SIMBULAN UV RESPONSE NORMAL UP
BIOCARTA CDMAC PATHWAY
KIM LRRC3B TARGETS
BENPORATH ES WITH H3K27ME3
HORIUCHI WTAP TARGETS UP
KEGG SMALL CELL LUNG CANCER
WOO LIVER CANCER RECURRENCE UP
DORN ADENOVIRUS INFECTION 12HR UP
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
BIOCARTA SODD PATHWAY
BIOCARTA TH1TH2 PATHWAY
NCI LYSOPHOSPHOLIPID PATHWAY
CLASPER LYMPHATIC VESSELS DURING METASTASIS DN
KEGG JAK STAT SIGNALING PATHWAY
TURASHVILI BREAST DUCTAL CARCINOMA VS DUCTAL NORMAL DN
DIRMEIER LMP1 RESPONSE LATE UP
NETPATH IL 6 PATHWAY
GILDEA METASTASIS
SEIKE LUNG CANCER POOR SURVIVAL
GALI TP53 TARGETS APOPTOTIC UP
AMIT EGF RESPONSE 20 HELA
KEGG ADIPOCYTOKINE SIGNALING PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
WEST ADRENOCORTICAL TUMOR DN
BASSO CD40 SIGNALING UP
MUELLER METHYLATED IN GLIOBLASTOMA
BIOCARTA NTHI PATHWAY
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
BIOCARTA BLYMPHOCYTE PATHWAY
ENK UV RESPONSE EPIDERMIS DN
BIOCARTA PPARA PATHWAY
SHIPP DLBCL CURED VS FATAL UP
VERRECCHIA RESPONSE TO TGFB1 C2
ZERBINI RESPONSE TO SULINDAC UP
WANG ESOPHAGUS CANCER VS NORMAL UP
FRIDMAN SENESCENCE UP
CROMER TUMORIGENESIS UP
FREDERICK PRKCI TARGETS
WU HBX TARGETS 2 DN
IVANOVA HEMATOPOIESIS STEM CELL
MAHADEVAN RESPONSE TO MP470 UP
CROMER METASTASIS DN
KEGG PROSTATE CANCER
FERRARI RESPONSE TO FENRETINIDE UP
BIOCARTA TID PATHWAY
KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY
NETPATH WNT PATHWAY DOWN
CORUM IKBA-NFKAPPABP65-NFKAPPABP50 COMPLEX
KEGG LEISHMANIA INFECTION
CHO NR4A1 TARGETS
CHEN HOXA5 TARGETS 9HR UP
KANNAN TP53 TARGETS UP
BIOCARTA DEATH PATHWAY
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
DOANE BREAST CANCER ESR1 DN
RICKMAN HEAD AND NECK CANCER C
WANG METHYLATED IN BREAST CANCER
RODWELL AGING KIDNEY UP
SENESE HDAC1 TARGETS UP
LIU TARGETS OF VMYB VS CMYB DN
INGA TP53 TARGETS
KIM WT1 TARGETS UP
PEPPER CHRONIC LYMPHOCYTIC LEUKEMIA UP
REACTOME P75NTR SIGNALS VIA NFKB
KEGG CYTOSOLIC DNA SENSING PATHWAY
BIOCARTA GRANULOCYTES PATHWAY
BIOCARTA TNFR2 PATHWAY
LINDSTEDT DENDRITIC CELL MATURATION C
MORI IMMATURE B LYMPHOCYTE UP
WANG HCP PROSTATE CANCER
BROWNE HCMV INFECTION 1HR UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
ELVIDGE HYPOXIA BY DMOG UP
AMIT EGF RESPONSE 120 MCF10A
BIOCARTA TOLL PATHWAY
KEGG NEUROACTIVE LIGAND RECEPTOR INTERACTION
NETPATH WNT PATHWAY UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
SMID BREAST CANCER RELAPSE IN BONE DN
VERRECCHIA EARLY RESPONSE TO TGFB1
NCI ACTIVATION OF PRO CASPASE 8
PRAMOONJAGO SOX4 TARGETS UP
KIM WT1 TARGETS 8HR UP
KOBAYASHI RESPONSE TO ROMIDEPSIN
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
LU TUMOR ENDOTHELIAL MARKERS UP
NETPATH IL 5 PATHWAY
BORCZUK MALIGNANT MESOTHELIOMA DN
POOLA INVASIVE BREAST CANCER DN
HAHTOLA SEZARY SYNDROM DN
REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
MUELLER COMMON TARGETS OF AML FUSIONS DN
TENEDINI MEGAKARYOCYTE MARKERS
BIOCARTA MITOCHONDRIA PATHWAY
CHEN LVAD SUPPORT OF FAILING HEART UP
LOPES METHYLATED IN COLON CANCER UP
MCBRYAN PUBERTAL BREAST 4 5WK UP
SAKAI CHRONIC HEPATITIS VS LIVER CANCER DN
KYNG DNA DAMAGE BY 4NQO OR GAMMA RADIATION
DAVICIONI MOLECULAR ARMS VS ERMS DN
LINDSTEDT DENDRITIC CELL MATURATION A
HOFMANN CELL LYMPHOMA DN
ELVIDGE HYPOXIA UP
LEE METASTASIS AND ALTERNATIVE SPLICING UP
XU HGF TARGETS REPRESSED BY AKT1 UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
BIOCARTA NKT PATHWAY
DACOSTA UV RESPONSE VIA ERCC3 TTD UP
BROWNE INTERFERON RESPONSIVE GENES
REACTOME SIGNALING IN IMMUNE SYSTEM
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
BIOCARTA LAIR PATHWAY
NCI TRAIL SIGNALINGCASP10
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
DAZARD UV RESPONSE CLUSTER G3
XU HGF TARGETS INDUCED BY AKT1 48HR UP
VART KSHV INFECTION ANGIOGENIC MARKERS UP
GILMORE CORE NFKB PATHWAY
DUTTA APOPTOSIS VIA NFKB
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER DN
TSAI RESPONSE TO IONIZING RADIATION
DELYS THYROID CANCER UP
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
DAZARD UV RESPONSE CLUSTER G4
NCI NFAT TFPATHWAY
HEIDENBLAD AMPLIFIED IN SOFT TISSUE CANCER
REN MIF TARGETS DN
ONDER CDH1 TARGETS 3 DN
ZHOU INFLAMMATORY RESPONSE LIVE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS RED UP
BIOCARTA ERYTH PATHWAY
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
DAZARD RESPONSE TO UV NHEK UP
WINTER HYPOXIA METAGENE
BROWNE HCMV INFECTION 8HR UP
NETPATH TNF ALPHA PATHWAY
NCI TNF SIGNALING
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX CHUK KPNA3 NFKB2 NFKBIB REL IKBKG NFKB1 NFKBIE RELB NFKBIA RELA TNIP2
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX SEC16A CHUK IKBKB NFKB2 REL IKBKG MAP3K14 RELA FBXW7 USP2
ISHIKAWA STING SIGNALING
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
FOSTER INFLAMMATORY RESPONSE LPS DN
GAURNIER PSMD4 TARGETS
LU TUMOR VASCULATURE UP
BIOCARTA FIBRINOLYSIS PATHWAY
FARMER BREAST CANCER CLUSTER 1
OSAWA TNF TARGETS
BIOCARTA HIVNEF PATHWAY
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
MARKEY RB1 CHRONIC LOF DN
GESERICK TERT TARGETS DN
BOQUEST STEM CELL CULTURED VS FRESH DN
KEGG T CELL RECEPTOR SIGNALING PATHWAY
BROWNE HCMV INFECTION 2HR UP
MOREAUX MULTIPLE MYELOMA BY TACI UP
LEE LIVER CANCER MYC E2F1 UP
BIOCARTA 41BB PATHWAY
SESTO RESPONSE TO UV C3
CORUM IKAPPAB KINASE COMPLEX IKBKB CHUK IKBKAP NFKBIA RELA MAP3K14
REACTOME DEATH RECEPTOR SIGNALLING
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
REACTOME VIRAL DSRNA TLR3 TRIF COMPLEX ACTIVATES RIP1
ZHOU INFLAMMATORY RESPONSE FIMA UP
REACTOME GPCR LIGAND BINDING
SANCHEZ MDM2 TARGETS
ZHU CMV ALL UP
ABE VEGFA TARGETS 2HR
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
CORUM IKAPPABALPHA-NFKAPPABP50-NFKAPPABP65 COMPLEX
AMIT EGF RESPONSE 60 MCF10A
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
NOJIMA SFRP2 TARGETS UP
NCI TCRCALCIUMPATHWAY
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
RODWELL AGING KIDNEY NO BLOOD UP
CHEN LVAD SUPPORT OF FAILING HEART DN
BIOCARTA EPONFKB PATHWAY
SATO SILENCED EPIGENETICALLY IN PANCREATIC CANCER
AUJLA IL22 AND IL17A SIGNALING
DORN ADENOVIRUS INFECTION 32HR DN
LEE LIVER CANCER MYC TGFA UP
REACTOME DOWNSTREAM EVENTS IN GPCR SIGNALING
CHANDRAN METASTASIS DN
WALLACE PROSTATE CANCER RACE UP
SAGIV CD24 TARGETS DN
KEGG ECM RECEPTOR INTERACTION
KEGG MAPK SIGNALING PATHWAY
ONDER CDH1 SIGNALING VIA CTNNB1
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
NCI HDL MEDIATED LIPID TRANSPORT
AMIT EGF RESPONSE 480 MCF10A
MAHADEVAN RESPONSE TO MP470 DN
DORN ADENOVIRUS INFECTION 12HR DN
BROWNE HCMV INFECTION 30MIN UP
HUPER BREAST BASAL VS LUMINAL DN
HARRIS HYPOXIA
KANG IMMORTALIZED BY TERT DN
NCI BH3 ONLY PROTEINS ASSOCIATE WITH AND INACTIVATE ANTI APOPTOTIC BCL 2 MEMBERS
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY
KAN RESPONSE TO ARSENIC TRIOXIDE
ENK UV RESPONSE KERATINOCYTE UP
NETPATH B CELL RECEPTOR PATHWAY DOWN
SOUCEK MYC TARGETS
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
BENPORATH PRC2 TARGETS
SCIAN INVERSED TARGETS OF TP53 AND TP73 DN
KEGG B CELL RECEPTOR SIGNALING PATHWAY
GENTILE UV LOW DOSE DN
NCI DOWNSTREAM TCR SIGNALING
LY AGING MIDDLE UP
LEE NEURAL CREST STEM CELL DN
MIZUKAMI HYPOXIA DN
KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
WILCOX PRESPONSE TO ROGESTERONE DN
NCI NGF INDEPENDANT TRKA ACTIVATION
BIOCARTA RNA PATHWAY
ST FAS SIGNALING PATHWAY
MENSE HYPOXIA UP
ST GA13 PATHWAY
BERENJENO TRANSFORMED BY RHOA FOREVER DN
AMIT EGF RESPONSE 60 HELA
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
REACTOME NF KB IS ACTIVATED AND SIGNALS SURVIVAL
MARKS HDAC TARGETS DN
DAZARD UV RESPONSE CLUSTER G2
MCLACHLAN DENTAL CARIES DN
AMIT SERUM RESPONSE 40 MCF10A
BROWNE HCMV INFECTION 4HR UP
WONG ENDOMETRIAL CANCER LATE
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
BIOCARTA STRESS PATHWAY
ZHU CMV 8 HR UP
BIERIE INFLAMMATORY RESPONSE TGFB1
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
SENESE HDAC1 AND HDAC2 TARGETS UP
EBAUER TARGETS OF PAX3 FOXO1 FUSION UP
ONDER CDH1 TARGETS 2 DN
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
CASTELLANO NRAS TARGETS UP
KEGG CHEMOKINE SIGNALING PATHWAY
VECCHI GASTRIC CANCER ADVANCED VS EARLY UP
STREICHER LSM1 TARGETS DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
KOBAYASHI EGFR SIGNALING 6HR DN
BIOCARTA KERATINOCYTE PATHWAY
XU HGF SIGNALING NOT VIA AKT1 48HR UP
TARTE PLASMA CELL VS PLASMABLAST UP
DASU IL6 SIGNALING UP
CHIBA RESPONSE TO TSA UP
HUPER BREAST BASAL VS LUMINAL UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
GOUYER TATI TARGETS UP
ZUCCHI METASTASIS DN
TANG SENESCENCE TP53 TARGETS UP
SMID BREAST CANCER BASAL UP
YAMASHITA METHYLATED IN PROSTATE CANCER
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
pseudomonas aeruginosaescherichia coliGeneSet Name
0.01390 0.00001NETPATH_TNF_ALPHA_PATHWAY_UP
0.11013 0.00000NETPATH_IL_2_PATHWAY_UP
0.00004 0.00000NETPATH_IL_1_PATHWAY_UP
0.00645 0.00044NCI_AMB2_NEUTROPHILS_PATHWAY
0.00238 0.00001NETPATH_IL_5_PATHWAY_UP
0.00000 0.00000NETPATH_IL_4_PATHWAY_DOWN
0.10186 0.00228NETPATH_B_CELL_RECEPTOR_PATHWAY_UP
0.08967 0.00129NETPATH_IL_4_PATHWAY_UP
0.00764 0.00002NETPATH_TNF_ALPHA_PATHWAY_DOWN
0.02903 0.00008NETPATH_EGFR1_PATHWAY_UP
0.05123 0.00023NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00049 0.00000NCI_IL23PATHWAY
0.06627 0.00028NETPATH_IL_9_PATHWAY_UP
0.03680 0.01619NCI_REG_GR_PATHWAY
0.04260 0.00831NCI_P53DOWNSTREAMPATHWAY
0.00843 0.01389GERY_CEBP_TARGETS
0.00003 0.01874NCI_ATF2_PATHWAY
0.01596 0.00000NETPATH_IL_3_PATHWAY_UP
0.05234 0.00010NCI_TNFPATHWAY
0.00151 0.00000NETPATH_IL_7_PATHWAY_UP
0.00000 0.00026ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.04053 0.00133SA_MMP_CYTOKINE_CONNECTION
0.00603 0.00003NETPATH_IL_1_PATHWAY
0.09153 0.00785NCI_IL6_7PATHWAY
0.07942 0.00686NCI_IL1PATHWAY
0.01244 0.00000NETPATH_IL_6_PATHWAY_UP
0.00848 0.00480NCI_CERAMIDE_PATHWAY
0.00075 0.00010NCI_CD40_PATHWAY
0.10947 0.00009NCI_NFKAPPABCANONICALPATHWAY
0.06462 0.00288CORUM_NFKB1-NFKB2-REL-RELA-RELB_COMPLEX
0.10413 0.01182NCI_REGULATED_PROTEOLYSIS_OF_P75NTR
0.00190 0.00474NCI_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.03519 0.01451CORUM_NFKB1-NFKB2-RELA-RELB_COMPLEX
0.12794 0.00288NCI_NFKAPPABATYPICALPATHWAY
0.01218 0.00004CORUM_CHUK-NFKB2-REL-IKBKG-SPAG9-NFKB1-NFKBIE-COPB2-TNIP1-NFKBIA-RELA-TNIP2_COMPLEX
0.01558 0.00000GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.17647 0.00008BIOCARTA_STEM_PATHWAY
0.04067 0.00000BIOCARTA_NFKB_PATHWAY
0.00000 0.00000MAHAJAN_RESPONSE_TO_IL1A_UP
0.03347 0.00000WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.03352 0.02803BIOCARTA_IL6_PATHWAY
0.04256 0.14273PIEPOLI_LGI1_TARGETS_DN
0.09315 0.01415LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.14165 0.00010NCI_ERBB_NETWORK_PATHWAY
0.00095 0.00015REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.00005 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.02041 0.00000BIOCARTA_IL1R_PATHWAY
0.08343 0.00033BIOCARTA_RELA_PATHWAY
0.00000 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.02390 0.00127LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.03876 0.14941ODONNELL_TFRC_TARGETS_UP
0.17959 0.06415KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.00802 0.00026IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.00000 0.00000AMIT_EGF_RESPONSE_40_HELA
0.07164 0.04754TOMIDA_METASTASIS_UP
0.00562 0.01590AMIT_EGF_RESPONSE_480_HELA
0.00094 0.00031JEON_SMAD6_TARGETS_UP
0.08410 0.02480MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00314 0.00386KEGG_COMPLEMENT_AND_COAGULATION_CASCADES
0.00381 0.00000THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.17965 0.05915HASINA_NOL7_TARGETS_UP
0.02604 0.12964NCI_DISSOLUTION_OF_FIBRIN_CLOT
0.13363 0.00220TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.02052 0.02437LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.15585 0.00529SABATES_COLORECTAL_ADENOMA_DN
0.00000 0.00000HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.01593 0.00081GENTILE_UV_HIGH_DOSE_UP
0.00817 0.00089DORN_ADENOVIRUS_INFECTION_48HR_DN
0.13427 0.00331KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.02176 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.00733 0.17729SCHEIDEREIT_IKK_INTERACTING_PROTEINS
0.10041 0.02148REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
0.00092 0.00109AMIT_SERUM_RESPONSE_60_MCF10A
0.16056 0.01809COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.00182 0.02827GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.00094 0.00112SABATES_COLORECTAL_ADENOMA_UP
0.06655 0.02877WOTTON_RUNX_TARGETS_UP
0.00003 0.00000REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00168 0.00009BIOCARTA_CD40_PATHWAY
0.01100 0.00155GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.00184 0.00046AMIT_EGF_RESPONSE_120_HELA
0.01532 0.05932BIOCARTA_RANKL_PATHWAY
0.00459 0.08667VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.00000 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.09007 0.18397BIOCARTA_AKT_PATHWAY
0.08239 0.00098GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.13378 0.01026PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.04250 0.05575SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.15655 0.10124HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.00110 0.00016REACTOME_HUMAN_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
0.17408 0.00002HELLER_SILENCED_BY_METHYLATION_UP
0.07565 0.11052KERLEY_RESPONSE_TO_CISPLATIN_UP
0.08574 0.00951BIOCARTA_CARDIACEGF_PATHWAY
0.06664 0.10195LAU_APOPTOSIS_CDKN2A_UP
0.00725 0.00769ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.04524 0.00006SMID_BREAST_CANCER_LUMINAL_B_DN
0.00043 0.00000ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.03149 0.00667DORN_ADENOVIRUS_INFECTION_24HR_DN
0.03822 0.00402BIOCARTA_IL17_PATHWAY
0.11253 0.00399FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.00267 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.04459 0.01653REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.06452 0.01397RUGO_STRESS_RESPONSE_SUBSET_F
0.04264 0.13447REACTOME_HDL_MEDIATED_LIPID_TRANSPORT
0.08387 0.07575SA_CASPASE_CASCADE
0.00407 0.06348SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.06576 0.17603CHASSOT_SKIN_WOUND
0.00000 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.10413 0.03462CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.00598 0.00005HUMMEL_BURKITTS_LYMPHOMA_DN
0.00027 0.00000KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.02825 0.17260MURAKAMI_UV_RESPONSE_1HR_DN
0.11287 0.18796BIOCARTA_IL3_PATHWAY
0.00359 0.11450GENTILE_UV_LOW_DOSE_UP
0.03983 0.11780GOLUB_ALL_VS_AML_DN
0.06634 0.00000KEGG_APOPTOSIS
0.09607 0.02479SHEN_SMARCA2_TARGETS_DN
0.05493 0.11170HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.08962 0.07744PEREZ_TP63_TARGETS
0.06344 0.00492CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.00000 0.00000HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00002 0.00000MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.19777 0.12303CORUM_MURR1-NFKAPPABP65-IKBA_COMPLEX
0.01456 0.00003CROONQUIST_STROMAL_STIMULATION_UP
0.13704 0.03171BIOCARTA_TALL1_PATHWAY
0.13427 0.11927BLUM_RESPONSE_TO_SALIRASIB_UP
0.05448 0.03683NCI_NFKAPPABALTERNATIVEPATHWAY
0.00361 0.01024SIMBULAN_UV_RESPONSE_NORMAL_UP
0.00389 0.02242BIOCARTA_CDMAC_PATHWAY
0.03852 0.00004KIM_LRRC3B_TARGETS
0.17931 0.01422BENPORATH_ES_WITH_H3K27ME3
0.10214 0.00002HORIUCHI_WTAP_TARGETS_UP
0.00846 0.02516KEGG_SMALL_CELL_LUNG_CANCER
0.16140 0.01595WOO_LIVER_CANCER_RECURRENCE_UP
0.19042 0.04767DORN_ADENOVIRUS_INFECTION_12HR_UP
0.06176 0.00220CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.12520 0.01445BIOCARTA_SODD_PATHWAY
0.07170 0.00439BIOCARTA_TH1TH2_PATHWAY
0.09661 0.09447NCI_LYSOPHOSPHOLIPID_PATHWAY
0.01213 0.00641CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN
0.19708 0.00009KEGG_JAK_STAT_SIGNALING_PATHWAY
0.14826 0.00475TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.12927 0.00000DIRMEIER_LMP1_RESPONSE_LATE_UP
0.07441 0.02986NETPATH_IL_6_PATHWAY
0.13362 0.10376GILDEA_METASTASIS
0.09189 0.00018SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.06810 0.04486GALI_TP53_TARGETS_APOPTOTIC_UP
0.00091 0.00089AMIT_EGF_RESPONSE_20_HELA
0.16371 0.00521KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.09083 0.10451TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.07059 0.12215WEST_ADRENOCORTICAL_TUMOR_DN
0.00006 0.00000BASSO_CD40_SIGNALING_UP
0.06034 0.19250MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.15889 0.00024BIOCARTA_NTHI_PATHWAY
0.05837 0.00702TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00113 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.13404 0.10036BIOCARTA_BLYMPHOCYTE_PATHWAY
0.09100 0.02283ENK_UV_RESPONSE_EPIDERMIS_DN
0.09219 0.17722BIOCARTA_PPARA_PATHWAY
0.05465 0.00206SHIPP_DLBCL_CURED_VS_FATAL_UP
0.00023 0.00832VERRECCHIA_RESPONSE_TO_TGFB1_C2
0.08983 0.02814ZERBINI_RESPONSE_TO_SULINDAC_UP
0.06142 0.00496WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.07194 0.00001FRIDMAN_SENESCENCE_UP
0.00771 0.00002CROMER_TUMORIGENESIS_UP
0.05597 0.03629FREDERICK_PRKCI_TARGETS
0.04253 0.00219WU_HBX_TARGETS_2_DN
0.06636 0.14262IVANOVA_HEMATOPOIESIS_STEM_CELL
0.00009 0.00000MAHADEVAN_RESPONSE_TO_MP470_UP
0.15618 0.07271CROMER_METASTASIS_DN
0.18992 0.19746KEGG_PROSTATE_CANCER
0.00003 0.00016FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.01521 0.00058BIOCARTA_TID_PATHWAY
0.00026 0.00000KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.09737 0.02713NETPATH_WNT_PATHWAY_DOWN
0.10409 0.05482CORUM_IKBA-NFKAPPABP65-NFKAPPABP50_COMPLEX
0.00366 0.00028KEGG_LEISHMANIA_INFECTION
0.19728 0.14879CHO_NR4A1_TARGETS
0.00776 0.00050CHEN_HOXA5_TARGETS_9HR_UP
0.02791 0.02721KANNAN_TP53_TARGETS_UP
0.00005 0.00002BIOCARTA_DEATH_PATHWAY
0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00000 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00121 0.08735CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.07176 0.04564DOANE_BREAST_CANCER_ESR1_DN
0.09446 0.00000RICKMAN_HEAD_AND_NECK_CANCER_C
0.17963 0.00010WANG_METHYLATED_IN_BREAST_CANCER
0.00266 0.15541RODWELL_AGING_KIDNEY_UP
0.16126 0.00079SENESE_HDAC1_TARGETS_UP
0.03971 0.01565LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.00399 0.02526INGA_TP53_TARGETS
0.00318 0.00002KIM_WT1_TARGETS_UP
0.19677 0.00611PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.02915 0.00047REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.00006 0.00000KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.04859 0.15379BIOCARTA_GRANULOCYTES_PATHWAY
0.00125 0.00004BIOCARTA_TNFR2_PATHWAY
0.08129 0.00116LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.17360 0.08736MORI_IMMATURE_B_LYMPHOCYTE_UP
0.06338 0.09404WANG_HCP_PROSTATE_CANCER
0.00403 0.12968BROWNE_HCMV_INFECTION_1HR_UP
0.15886 0.08966HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.03582 0.01098ELVIDGE_HYPOXIA_BY_DMOG_UP
0.00069 0.00004AMIT_EGF_RESPONSE_120_MCF10A
0.03026 0.05426BIOCARTA_TOLL_PATHWAY
0.14370 0.02690KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
0.13395 0.00227NETPATH_WNT_PATHWAY_UP
0.00003 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00340 0.00008BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.19699 0.01277SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
0.00598 0.10933VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.06293 0.01398NCI_ACTIVATION_OF_PRO_CASPASE_8
0.00151 0.00005PRAMOONJAGO_SOX4_TARGETS_UP
0.06159 0.07735KIM_WT1_TARGETS_8HR_UP
0.14390 0.05937KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.04258 0.02690PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.09212 0.08745YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.03006 0.00080LU_TUMOR_ENDOTHELIAL_MARKERS_UP
0.11369 0.04832NETPATH_IL_5_PATHWAY
0.02033 0.06058BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.01593 0.16851POOLA_INVASIVE_BREAST_CANCER_DN
0.09523 0.00330HAHTOLA_SEZARY_SYNDROM_DN
0.00044 0.00121REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.00016 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.01543 0.03638MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.09360 0.00011TENEDINI_MEGAKARYOCYTE_MARKERS
0.07180 0.03856BIOCARTA_MITOCHONDRIA_PATHWAY
0.11056 0.00159CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.10437 0.00795LOPES_METHYLATED_IN_COLON_CANCER_UP
0.13408 0.05631MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.13870 0.04442SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.06042 0.01938KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION
0.15693 0.10217DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
0.00387 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.14280 0.06043HOFMANN_CELL_LYMPHOMA_DN
0.10177 0.01124ELVIDGE_HYPOXIA_UP
0.15471 0.13963LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
0.10004 0.00330XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.00150 0.03327YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.03928 0.00003BIOCARTA_NKT_PATHWAY
0.00048 0.18515DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
0.10336 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.04260 0.13298REACTOME_SIGNALING_IN_IMMUNE_SYSTEM
0.10385 0.00807TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.13570 0.05748BIOCARTA_LAIR_PATHWAY
0.04261 0.02189NCI_TRAIL__SIGNALING
0.00004 0.00000KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00321 0.00510DAZARD_UV_RESPONSE_CLUSTER_G3
0.06674 0.00136XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.02603 0.00000VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.00340 0.00003GILMORE_CORE_NFKB_PATHWAY
0.00086 0.00000DUTTA_APOPTOSIS_VIA_NFKB
0.02516 0.09897SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN
0.03182 0.00126TSAI_RESPONSE_TO_IONIZING_RADIATION
0.03069 0.00200DELYS_THYROID_CANCER_UP
0.00000 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.01592 0.00000DER_IFN_GAMMA_RESPONSE_UP
0.00111 0.16523DAZARD_UV_RESPONSE_CLUSTER_G4
0.13386 0.00004NCI_NFAT_TFPATHWAY
0.18633 0.17131HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
0.10143 0.06867REN_MIF_TARGETS_DN
0.00003 0.00000ONDER_CDH1_TARGETS_3_DN
0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00397 0.11790GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.04281 0.00332BIOCARTA_ERYTH_PATHWAY
0.01171 0.04537NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.00610 0.00004HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.00593 0.00438NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00080 0.00002DAZARD_RESPONSE_TO_UV_NHEK_UP
0.10229 0.02164WINTER_HYPOXIA_METAGENE
0.10159 0.00256BROWNE_HCMV_INFECTION_8HR_UP
0.19660 0.00219NETPATH_TNF_ALPHA_PATHWAY
0.17909 0.01751NCI_TNF_SIGNALING
0.00066 0.00012CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_CHUK_KPNA3_NFKB2_NFKBIB_REL_IKBKG__NFKB1_NFKBIE_RELB__NFKBIA_RELA_TNIP2
0.06210 0.05473CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_SEC16A_CHUK_IKBKB_NFKB2_REL_IKBKG_MAP3K14_RELA_FBXW7_USP2
0.10531 0.00301ISHIKAWA_STING_SIGNALING
0.07679 0.10160GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.00185 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00036 0.00000GAURNIER_PSMD4_TARGETS
0.06642 0.00003LU_TUMOR_VASCULATURE_UP
0.05841 0.00489BIOCARTA_FIBRINOLYSIS_PATHWAY
0.03450 0.00000FARMER_BREAST_CANCER_CLUSTER_1
0.00364 0.00142OSAWA_TNF_TARGETS
0.19684 0.00020BIOCARTA_HIVNEF_PATHWAY
0.01071 0.00071SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.05916 0.09710MARKEY_RB1_CHRONIC_LOF_DN
0.00178 0.00083GESERICK_TERT_TARGETS_DN
0.18974 0.17948BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.03351 0.10958KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.00000 0.00014BROWNE_HCMV_INFECTION_2HR_UP
0.08700 0.04061MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
0.16348 0.08000LEE_LIVER_CANCER_MYC_E2F1_UP
0.11415 0.00135BIOCARTA_41BB_PATHWAY
0.00703 0.00001SESTO_RESPONSE_TO_UV_C3
0.13469 0.06849CORUM_IKAPPAB_KINASE_COMPLEX_IKBKB_CHUK_IKBKAP_NFKBIA_RELA_MAP3K14
0.06355 0.00004REACTOME_DEATH_RECEPTOR_SIGNALLING
0.00051 0.00000GEISS_RESPONSE_TO_DSRNA_UP
0.02559 0.00000GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.00537 0.00653SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.00376 0.00003CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.00153 0.00018REACTOME_VIRAL_DSRNA_TLR3_TRIF_COMPLEX_ACTIVATES_RIP1
0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.00049 0.00318REACTOME_GPCR_LIGAND_BINDING
0.06751 0.01436SANCHEZ_MDM2_TARGETS
0.13854 0.00000ZHU_CMV_ALL_UP
0.09694 0.04288ABE_VEGFA_TARGETS_2HR
0.00093 0.00010LEE_LIVER_CANCER_HEPATOBLAST
0.00102 0.00003NAGASHIMA_EGF_SIGNALING_UP
0.04481 0.00082AMIT_DELAYED_EARLY_GENES
0.11737 0.04958CORUM_IKAPPABALPHA-NFKAPPABP50-NFKAPPABP65_COMPLEX
0.00367 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.00066 0.00000KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.06631 0.00018NOJIMA_SFRP2_TARGETS_UP
0.12883 0.00732NCI_TCRCALCIUMPATHWAY
0.00003 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.02594 0.01400SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.08414 0.05537RODWELL_AGING_KIDNEY_NO_BLOOD_UP
0.09879 0.19530CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.00600 0.00507BIOCARTA_EPONFKB_PATHWAY
0.09845 0.10214SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.04032 0.00129AUJLA_IL22_AND_IL17A_SIGNALING
0.00267 0.00003DORN_ADENOVIRUS_INFECTION_32HR_DN
0.17247 0.07586LEE_LIVER_CANCER_MYC_TGFA_UP
0.00773 0.04949REACTOME_DOWNSTREAM_EVENTS_IN_GPCR_SIGNALING
0.00166 0.00634CHANDRAN_METASTASIS_DN
0.03564 0.00004WALLACE_PROSTATE_CANCER_RACE_UP
0.00003 0.00010SAGIV_CD24_TARGETS_DN
0.14968 0.00613KEGG_ECM_RECEPTOR_INTERACTION
0.06687 0.19572KEGG_MAPK_SIGNALING_PATHWAY
0.00094 0.00015ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.04274 0.01179GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.03815 0.13302NCI_HDL_MEDIATED_LIPID_TRANSPORT
0.04271 0.12258AMIT_EGF_RESPONSE_480_MCF10A
0.00187 0.00317MAHADEVAN_RESPONSE_TO_MP470_DN
0.06010 0.00337DORN_ADENOVIRUS_INFECTION_12HR_DN
0.02842 0.07149BROWNE_HCMV_INFECTION_30MIN_UP
0.06151 0.02150HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.00391 0.00034HARRIS_HYPOXIA
0.07448 0.19474KANG_IMMORTALIZED_BY_TERT_DN
0.04046 0.02523NCI_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS
0.08417 0.00007KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.03882 0.03651KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
0.00906 0.02558KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.00000 0.01710ENK_UV_RESPONSE_KERATINOCYTE_UP
0.06465 0.04764NETPATH_B_CELL_RECEPTOR_PATHWAY_DOWN
0.00251 0.00037SOUCEK_MYC_TARGETS
0.00023 0.05842TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.14502 0.00331BENPORATH_PRC2_TARGETS
0.17466 0.00384SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.00559 0.09546KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.00316 0.08643GENTILE_UV_LOW_DOSE_DN
0.09004 0.03029NCI_DOWNSTREAM_TCR_SIGNALING
0.16829 0.00233LY_AGING_MIDDLE_UP
0.08405 0.02158LEE_NEURAL_CREST_STEM_CELL_DN
0.08988 0.03300MIZUKAMI_HYPOXIA_DN
0.06566 0.00438KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.00110 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.00126 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.00006 0.00003DAUER_STAT3_TARGETS_UP
0.01598 0.15754WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.18210 0.11914NCI_NGF_INDEPENDANT_TRKA_ACTIVATION
0.17993 0.00522BIOCARTA_RNA_PATHWAY
0.00311 0.14756ST_FAS_SIGNALING_PATHWAY
0.10399 0.09188MENSE_HYPOXIA_UP
0.03144 0.07256ST_GA13_PATHWAY
0.00379 0.00016BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.17983 0.00523AMIT_EGF_RESPONSE_60_HELA
0.02053 0.08973ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00492 0.00247REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.07473 0.00070MARKS_HDAC_TARGETS_DN
0.01158 0.00004DAZARD_UV_RESPONSE_CLUSTER_G2
0.00005 0.00002MCLACHLAN_DENTAL_CARIES_DN
0.00028 0.00142AMIT_SERUM_RESPONSE_40_MCF10A
0.06023 0.00000BROWNE_HCMV_INFECTION_4HR_UP
0.13355 0.06386WONG_ENDOMETRIAL_CANCER_LATE
0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.01473 0.00884BIOCARTA_STRESS_PATHWAY
0.02114 0.00000ZHU_CMV_8_HR_UP
0.00508 0.01522BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.08424 0.00000BIOCARTA_INFLAM_PATHWAY
0.00000 0.00000SANA_TNF_SIGNALING_UP
0.03137 0.00002SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.11776 0.17326EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.00503 0.00002ONDER_CDH1_TARGETS_2_DN
0.00000 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.13383 0.00040CASTELLANO_NRAS_TARGETS_UP
0.02579 0.00217KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.12436 0.00166VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.13443 0.07719STREICHER_LSM1_TARGETS_DN
0.00002 0.00044UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00180 0.00132XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.00269 0.00015KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.03442 0.02283BIOCARTA_KERATINOCYTE_PATHWAY
0.04449 0.05998XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.02025 0.03677TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
0.00000 0.00015DASU_IL6_SIGNALING_UP
0.16041 0.02614CHIBA_RESPONSE_TO_TSA_UP
0.12933 0.00000HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.00000 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.06637 0.03224GOUYER_TATI_TARGETS_UP
0.00002 0.00000ZUCCHI_METASTASIS_DN
0.19122 0.14400TANG_SENESCENCE_TP53_TARGETS_UP
0.18445 0.00694SMID_BREAST_CANCER_BASAL_UP
0.15907 0.00355YAMASHITA_METHYLATED_IN_PROSTATE_CANCER